Updated:
The Kush Fund
The Kush Fund evaluates investment opportunities for investors in the legal, medicinal, and recreational marijuana and cannabis industry. It was established to...
The Kush Fund
The Kush Fund evaluates investment opportunities for investors in the legal, medicinal, and recreational marijuana and cannabis industry. It was established to take advantage of investments across medical, recreational, services, research, technology, and agricultural markets. The fund positions itself as a financing source dedicated to growth opportunities in the nascent cannabis and marijuana industry, including agricultural operations, agri-tech, medical distribution, and med-tech.
General information
Firm type
Private Equity
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, ON, Canada
Principals
Marianne Godwin
CFA, Director
Gabriel Patterson
Managing Director
Victoria Colby
Director & Corporate Secretary
Sector focus
Frequently asked questions
Why does The Kush Fund concentrate only on Canada, and not the U.S. market?
Cannabis remains a Schedule I controlled substance under U.S. federal law, which creates banking, tax, and interstate commerce barriers that many institutional investors cannot accept. Canada's 2018 federal legalization provides a clear regulatory framework, allowing the fund to underwrite assets without the same legal uncertainty. This constraint is strategic — it limits the competitive set and allows the fund to operate where traditional banks and pension funds remain cautious.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: